vs

Side-by-side financial comparison of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) and NETSTREIT Corp. (NTST). Click either name above to swap in a different company.

NETSTREIT Corp. is the larger business by last-quarter revenue ($57.1M vs $49.9M, roughly 1.1× MARAVAI LIFESCIENCES HOLDINGS, INC.). NETSTREIT Corp. runs the higher net margin — 10.0% vs -71.6%, a 81.6% gap on every dollar of revenue. On growth, NETSTREIT Corp. posted the faster year-over-year revenue change (24.3% vs -11.8%). Over the past eight quarters, NETSTREIT Corp.'s revenue compounded faster (20.1% CAGR vs -11.9%).

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

NETSTREIT Corp. is a US-headquartered real estate investment trust (REIT) that specializes in acquiring and operating a diversified portfolio of single-tenant net lease commercial properties. Its asset portfolio covers retail, industrial and office categories, primarily catering to investment-grade corporate tenants across the United States market.

MRVI vs NTST — Head-to-Head

Bigger by revenue
NTST
NTST
1.1× larger
NTST
$57.1M
$49.9M
MRVI
Growing faster (revenue YoY)
NTST
NTST
+36.1% gap
NTST
24.3%
-11.8%
MRVI
Higher net margin
NTST
NTST
81.6% more per $
NTST
10.0%
-71.6%
MRVI
Faster 2-yr revenue CAGR
NTST
NTST
Annualised
NTST
20.1%
-11.9%
MRVI

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MRVI
MRVI
NTST
NTST
Revenue
$49.9M
$57.1M
Net Profit
$-35.7M
$5.7M
Gross Margin
25.8%
Operating Margin
-117.9%
34.1%
Net Margin
-71.6%
10.0%
Revenue YoY
-11.8%
24.3%
Net Profit YoY
-37.7%
235.9%
EPS (diluted)
$-0.24
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRVI
MRVI
NTST
NTST
Q1 26
$57.1M
Q4 25
$49.9M
$52.5M
Q3 25
$41.6M
$48.3M
Q2 25
$47.4M
$48.3M
Q1 25
$46.9M
$45.9M
Q4 24
$56.6M
$44.1M
Q3 24
$69.0M
$41.4M
Q2 24
$69.4M
$39.6M
Net Profit
MRVI
MRVI
NTST
NTST
Q1 26
$5.7M
Q4 25
$-35.7M
$1.3M
Q3 25
$-25.6M
$618.0K
Q2 25
$-39.6M
$3.3M
Q1 25
$-29.9M
$1.7M
Q4 24
$-25.9M
$-5.4M
Q3 24
$-97.1M
$-5.3M
Q2 24
$-9.8M
$-2.3M
Gross Margin
MRVI
MRVI
NTST
NTST
Q1 26
Q4 25
25.8%
Q3 25
13.6%
Q2 25
16.4%
Q1 25
16.5%
Q4 24
34.3%
Q3 24
46.7%
Q2 24
44.4%
Operating Margin
MRVI
MRVI
NTST
NTST
Q1 26
34.1%
Q4 25
-117.9%
2.6%
Q3 25
-98.6%
1.3%
Q2 25
-139.8%
6.8%
Q1 25
-104.9%
3.7%
Q4 24
-66.7%
-12.3%
Q3 24
-239.9%
-12.8%
Q2 24
-19.4%
-5.8%
Net Margin
MRVI
MRVI
NTST
NTST
Q1 26
10.0%
Q4 25
-71.6%
2.5%
Q3 25
-61.4%
1.3%
Q2 25
-83.5%
6.8%
Q1 25
-63.9%
3.7%
Q4 24
-45.8%
-12.3%
Q3 24
-140.6%
-12.8%
Q2 24
-14.1%
-5.8%
EPS (diluted)
MRVI
MRVI
NTST
NTST
Q1 26
$0.32
Q4 25
$-0.24
$0.01
Q3 25
$-0.18
$0.01
Q2 25
$-0.27
$0.04
Q1 25
$-0.21
$0.02
Q4 24
$-0.21
$-0.07
Q3 24
$-0.68
$-0.07
Q2 24
$-0.07
$-0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRVI
MRVI
NTST
NTST
Cash + ST InvestmentsLiquidity on hand
$216.9M
Total DebtLower is stronger
$291.8M
Stockholders' EquityBook value
$212.4M
$1.5B
Total Assets
$770.6M
$2.8B
Debt / EquityLower = less leverage
1.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRVI
MRVI
NTST
NTST
Q1 26
Q4 25
$216.9M
Q3 25
$243.6M
Q2 25
$269.9M
Q1 25
$285.1M
Q4 24
$322.4M
Q3 24
$578.2M
Q2 24
$573.2M
Total Debt
MRVI
MRVI
NTST
NTST
Q1 26
Q4 25
$291.8M
$1.1B
Q3 25
$292.8M
$1.1B
Q2 25
$293.9M
$926.6M
Q1 25
$294.9M
$913.3M
Q4 24
$295.9M
$868.3M
Q3 24
$521.7M
$778.7M
Q2 24
$522.5M
$726.2M
Stockholders' Equity
MRVI
MRVI
NTST
NTST
Q1 26
$1.5B
Q4 25
$212.4M
$1.4B
Q3 25
$245.4M
$1.3B
Q2 25
$265.9M
$1.3B
Q1 25
$300.6M
$1.3B
Q4 24
$325.3M
$1.3B
Q3 24
$344.9M
$1.3B
Q2 24
$434.7M
$1.3B
Total Assets
MRVI
MRVI
NTST
NTST
Q1 26
$2.8B
Q4 25
$770.6M
$2.6B
Q3 25
$849.2M
$2.5B
Q2 25
$897.0M
$2.3B
Q1 25
$959.8M
$2.3B
Q4 24
$1.0B
$2.3B
Q3 24
$1.3B
$2.2B
Q2 24
$1.4B
$2.1B
Debt / Equity
MRVI
MRVI
NTST
NTST
Q1 26
Q4 25
1.37×
0.76×
Q3 25
1.19×
0.84×
Q2 25
1.11×
0.70×
Q1 25
0.98×
0.70×
Q4 24
0.91×
0.65×
Q3 24
1.51×
0.58×
Q2 24
1.20×
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRVI
MRVI
NTST
NTST
Operating Cash FlowLast quarter
$-22.8M
Free Cash FlowOCF − Capex
$-24.9M
FCF MarginFCF / Revenue
-49.9%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-70.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRVI
MRVI
NTST
NTST
Q1 26
Q4 25
$-22.8M
$109.5M
Q3 25
$-15.2M
$28.0M
Q2 25
$-10.3M
$30.6M
Q1 25
$-9.4M
$22.1M
Q4 24
$-14.6M
$90.2M
Q3 24
$13.1M
$25.1M
Q2 24
$17.4M
$25.4M
Free Cash Flow
MRVI
MRVI
NTST
NTST
Q1 26
Q4 25
$-24.9M
Q3 25
$-18.1M
Q2 25
$-13.1M
Q1 25
$-14.6M
Q4 24
$-20.5M
Q3 24
$4.5M
Q2 24
$7.9M
FCF Margin
MRVI
MRVI
NTST
NTST
Q1 26
Q4 25
-49.9%
Q3 25
-43.4%
Q2 25
-27.7%
Q1 25
-31.2%
Q4 24
-36.2%
Q3 24
6.6%
Q2 24
11.4%
Capex Intensity
MRVI
MRVI
NTST
NTST
Q1 26
Q4 25
4.2%
Q3 25
7.0%
Q2 25
6.1%
Q1 25
11.2%
Q4 24
10.3%
Q3 24
12.4%
Q2 24
13.8%
Cash Conversion
MRVI
MRVI
NTST
NTST
Q1 26
Q4 25
82.46×
Q3 25
45.27×
Q2 25
9.36×
Q1 25
13.06×
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

NTST
NTST

Rental revenue (including reimbursable)$54.0M95%
Other$3.0M5%

Related Comparisons